Autism and Other Developmental Disabilities, Surveillance, Research, and Prevention
Active
- Assistance listing
- 93.998
- Agency
-
Centers for Disease Control and Prevention
Department of Health and Human Services
- Grant awards
- 6 $20,970,497 in federal obligations
Program facts
- Also known as
- Autism and Other Developmental Disabilities
- Assistance type
-
- Cooperative Agreement
- Treasury account
-
- 75-0958-1-1-550
Program details come from SAM.gov Assistance Listings. Updated . Grant award figures come from USAspending.gov.
About this program
The Department of Health and Human Services Centers for Disease Control and Prevention funds population-based surveillance of autism spectrum disorder and other developmental disabilities through the Autism and Developmental Disabilities Monitoring (ADDM) Network under Assistance Listing 93.998, with the most recent grant awards dated January 1, 2019.
The program has not posted new grant opportunities recently. The last solicitation (CDC-RFA-DD19-1901) closed on October 1, 2018. No active opportunities are currently listed, and no grant awards have been disbursed since January 2019—more than seven years ago. This program appears dormant for new applications and warrants careful verification of current funding status before pursuit.
When active, the program funds state health agencies, universities, and public and private nonprofit organizations to implement multi-source surveillance systems tracking autism spectrum disorder and intellectual disability prevalence among children at ages 4, 8, and 16 years. Funded work includes establishing and maintaining access to both health and education data sources, staff training, manuscript publication, stakeholder engagement, and strategic performance monitoring. Recent awards supported surveillance operations at sites including Washington University (St. Louis metropolitan area), University of Arizona (Arizona), University of Maryland, Vanderbilt University Medical Center (Tennessee), University of Wisconsin, and University of Arkansas.
The program is structured exclusively around Cooperative Agreements. Six awards totaling $21 million in federal obligated funds were disbursed in 2019. Individual award magnitudes ranged from approximately $3.1 million to $4 million per cooperative agreement, with project performance periods of up to five years (including one-year initial budget periods). The Centers for Disease Control and Prevention provided all identified federal funding.
Recent award recipients included Washington University ($3,348,635 for metropolitan St. Louis autism and developmental disabilities surveillance), University of Arizona ($3,257,572 for Arizona developmental disabilities surveillance), and University of Maryland ($4,009,589 for Maryland ADDM network enhancement). All six awards from the 2019 cohort specified completion dates between April 2023 and December 2023.
Eligible applicants include state agencies, consumer organizations, local entities, public nonprofit institutions, federally recognized Indian tribal governments, and private nonprofit organizations. Application review emphasizes scientific and technical merit, clarity of purpose, personnel qualifications, dissemination potential to state and local health departments, and budget reasonableness. Project periods of performance extend from one to five years, with continuation funding available non-competitively contingent on satisfactory progress.
Objective and description
- Objective
This funding supports State health agencies, universities, and public and private nonprofit organizations in planning, implementing, coordinating, or evaluating programs related to autism and other developmental disabilities and the improvement of in
Eligibility
- Beneficiary eligibility
State; Consumer; Local; Public nonprofit institution/organization; Federally Recognized Indian Tribal Governments; Private nonprofit institution/organizations and others.
- Credentials and documentation
Credentials/Documentation (083): Applicants should document the need for assistance, state the objectives of the project, outline the method of operation, describe the evaluation procedures and provide a budget justification of funds requested. Costs for nonprofit recipients will be determined in accordance with HHS Regulations, 45 CFR Part 74, Subpart Q. OMB Circular No. A-87 applies to this program.
- Uses of assistance
Funds may be used to strengthen, expand, build upon or enhance research, surveillance, health promotion, education, and prevention/intervention activities that contribute to the mission and activities of the Division of Human Development and Disability (DHDD). Funds may be used to improve and strengthen State and local public health infrastructure by providing technical assistance to other appropriate health agencies, organizations, special groups or coalitions. Funds may be used to support capacity building, program planning, development, implementation, evaluation, and surveillance for autism and other developmental disabilities, and infant and child health and developmental outcomes, including related health promotion, education and training, and prevention/intervention. Funds may also be used to coordinate the dissemination of prevention information to the general public, target populations, state and local agencies, and public and private sector organizations in the United States. Funds may not be used for direct curative or rehabilitative services.
- Length and time phasing of assistance
Financial assistance is provided for a 12-month budget period with a period of performance of up to five years subject to the availability of funds and satisfactory progress of the recipient.
How to apply
- Criteria for selecting proposals
In general, applications are reviewed on the basis of scientific/technical merit, with attention given to such matters as: (1) The degree to which the applicant satisfies the essential requirements and possesses other desired characteristics, such as depth, breadth, and merit of the overall application relative to the types of projects proposed; (2) clarity of purpose and overall qualifications, adequacy and appropriateness of personnel to accomplish proposed prevention research projects and demonstration projects, and the nation's health priorities and needs; (3) ability to generalize, translate and disseminate to State or local health departments, and other appropriate national regional, and local public health agencies and organizations; (4) reasonableness of the proposed budget in relation to the work proposed.
- Award procedure
After review and approval, a Notice of Award from the CDC Office of Grant Services is prepared and signed by an authorized Grants Management Officer. The initial award provides funds for first budget period (usually 12 months) and Notice of Award indicates support recommended for the remainder of project period, allocation of Federal funds by budget categories, and special conditions, if any. Cooperative agreement awards and grants, competitive and single eligibility, are determined by an internal objective committee review process at CDC, including peer reviews for research activities. Awards will be based on evaluation criteria set forth in the respective Notice of Funding Opportunity, the availability of funds, and such other significant factors as deemed necessary and appropriate by CDC.
- Renewals
Project period of performance is 1 to 5 years. After initial awards, and subject to availability of funds, projects may be continued non-competitively contingent upon satisfactory progress by the recipient (as documented in required reports) and the determination that continued funding is in the best interest of the Federal government.
Grant opportunities
| Opportunity | Status | Posted | Applications due |
|---|---|---|---|
| Enhancing Public Health Surveillance of Autism Spectrum Disorder through the Autism and Developmental Disabilities Monitoring (ADDM) Network | Closed |
Grant awards
Top recipients by federal obligations
| Rank | Recipient | Federal obligations | Share |
|---|---|---|---|
| 1 | The Johns Hopkins University | $4,009,590 | 19% |
| 2 | University Of Arkansas For Medical Sciences | $3,771,690 | 18% |
| 3 | University Of Wisconsin System | $3,489,247 | 17% |
| 4 | The Washington University | $3,348,636 | 16% |
| 5 | University Of Arizona | $3,257,572 | 16% |
| 6 | Vanderbilt University Medical Center | $3,093,763 | 15% |
Federal obligations by fiscal year
| Fiscal year | Federal obligations |
|---|---|
| FY2024 | $16,431,963 |
| FY2023 | $33,660,973 |
| FY2022 | $14,351,263 |
| FY2021 | $4,500,000 |
| FY2020 | $10,344,085 |
| FY2019 | $5,100,000 |
Quick answers
What is Assistance Listing 93.998?
Assistance Listing 93.998 is Autism and Other Developmental Disabilities, Surveillance, Research, and Prevention, a federal grant program run by Centers for Disease Control and Prevention (Department of Health and Human Services).
What is the CFDA number for Autism and Other Developmental Disabilities, Surveillance, Research, and Prevention?
Its CFDA number is 93.998: Assistance Listing numbers were called CFDA numbers before 2018.
How much funding has Assistance Listing 93.998 awarded?
6 grant awards under 93.998 have obligated $20,970,497 in federal funds to 6 recipients.
Who receives the most funding from 93.998?
The recipients obligated the most under Autism and Other Developmental Disabilities, Surveillance, Research, and Prevention are The Johns Hopkins University ($4,009,590), University Of Arkansas For Medical Sciences ($3,771,690) and University Of Wisconsin System ($3,489,247).
Are there open grant opportunities under 93.998?
No opportunity listed under 93.998 is open now. The latest, Enhancing Public Health Surveillance of Autism Spectrum Disorder through the Autism and Developmental Disabilities Monitoring (ADDM) Network, was posted on August 1, 2018.
On GovTribe
See this program's full record
- Every grant award and opportunity under it
- Funding by recipient, agency and assistance type
- Alerts for new opportunities
- Ask GovTribe AI about this program